Optimising neonatal antiretroviral therapy using raltegravir: a qualitative analysis of healthcare workers’ and caregivers’ perspectives

BACKGROUND: In 2020, Zimbabwe adopted the WHO’s recommendation to use raltegravir (RAL) granule-based regimens for treatment of neonates identified with HIV at the time of birth testing. This study explores the acceptability of RAL granules by caregivers and healthcare workers (HCWs). METHODS: Inter...

Descripción completa

Detalles Bibliográficos
Autores principales: Katirayi, Leila, Stecker, Carl, Andifasi, Precious, Mushavi, Angela, Tiwari, Pradisha, Jakazi, Chioniso, Maphosa, Talent, Thorsen, Viva, Murandu, Mildrate, Gombakomba, Gladys, Mungati, More, Denoeud-Ndam, Lise, Rivadeneira, Emilia, Weber, Rachel, Hrapcak, Susan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Neonatology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9330340/
https://www.ncbi.nlm.nih.gov/pubmed/36053612
http://dx.doi.org/10.1136/bmjpo-2022-001474

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9330340/
https://www.ncbi.nlm.nih.gov/pubmed/36053612
http://dx.doi.org/10.1136/bmjpo-2022-001474

Ejemplares similares